Purdue Pharma agrees to $7.4B opioid settlement with states
Digest more
All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.
New York lawmakers are trying to pass a law that would clarify the Mental Hygiene Law, to ensure that money from a landmark opioid settlement can't be diverted to the state's general coffers.